NeoPhore
Pre-clinicalTherapeutic approach transiently blocks DNA MMR to mimic known robust and durable clinical responses to immunotherapy of patients with genetically MMR-deficient…
Founded
2017
Focus
Small Molecules
About
Therapeutic approach transiently blocks DNA MMR to mimic known robust and durable clinical responses to immunotherapy of patients with genetically MMR-deficient…
Funding History
2Total raised: $27.2M
Series A$24MClaris VenturesNov 15, 2022
Seed$3.2MCancer Research UKSep 15, 2020
Company Info
TypePrivate
Founded2017
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile